These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 25741433

  • 1. Antimicrobial Susceptibilities of Clinical Acinetobacter baumannii Isolates With Different Genotypes.
    Altun HU, Yagci S, Bulut C, Sahin H, Kinikli S, Adiloglu AK, Demiroz AP.
    Jundishapur J Microbiol; 2014 Dec; 7(12):e13347. PubMed ID: 25741433
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
    Sheng WH, Wang JT, Li SY, Lin YC, Cheng A, Chen YC, Chang SC.
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
    [Abstract] [Full Text] [Related]

  • 3. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H, Kus H, Arslan U, Tuncer I.
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [Abstract] [Full Text] [Related]

  • 4. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.
    Maraki S, Mantadakis E, Mavromanolaki VE, Kofteridis DP, Samonis G.
    Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437
    [Abstract] [Full Text] [Related]

  • 5. [Antimicrobial susceptibility and molecular characterization of multidrug-resistant Acinetobacter baumannii isolated in an university hospital].
    Direkel Ş, Çopur Çiçek A, Karagöz A, Aydoğan Ejder N, Oktay E, Delialioğlu N, Özgümüş OB, Durmaz R.
    Mikrobiyol Bul; 2016 Oct; 50(4):522-534. PubMed ID: 28124957
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of synergistic activity of antibiotic combinations in extensive drug-resistant Acinetobacter species using checkerboard assay.
    Abdel Halim RM, Saber SM, Fahim NAE.
    J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36762530
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE, Bayram A, Balci I.
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [Abstract] [Full Text] [Related]

  • 8. [Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].
    Sarı B, Baran I, Alaçam S, Mumcuoğlu İ, Kurşun Ş, Aksu N.
    Mikrobiyol Bul; 2015 Apr; 49(2):249-58. PubMed ID: 26167825
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
    Seifert H, Müller C, Stefanik D, Higgins PG, Miller A, Kresken M.
    J Antimicrob Chemother; 2020 Sep 01; 75(9):2616-2621. PubMed ID: 32516359
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y, Telli M, Altunçekiç Yıldırım A, Çalgın MK.
    Mikrobiyol Bul; 2016 Jul 01; 50(3):460-5. PubMed ID: 27525401
    [Abstract] [Full Text] [Related]

  • 11. Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).
    Seifert H, Blondeau J, Lucaßen K, Utt EA.
    J Glob Antimicrob Resist; 2022 Dec 01; 31():82-89. PubMed ID: 35948242
    [Abstract] [Full Text] [Related]

  • 12. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C, Xie W, Zhang W, Ye Z, Wu H.
    Zhonghua Shao Shang Za Zhi; 2014 Apr 01; 30(2):166-70. PubMed ID: 24989663
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii.
    Leelasupasri S, Santimaleeworagun W, Jitwasinkul T.
    J Pathog; 2018 Apr 01; 2018():3893492. PubMed ID: 29593912
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V.
    J Med Assoc Thai; 2011 Aug 01; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [Abstract] [Full Text] [Related]

  • 15. Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii.
    Temocin F, Erdinc FS, Tulek N, Demirelli M, Ertem G, Kinikli S, Koksal E.
    Braz J Microbiol; 2015 Aug 01; 46(4):1119-24. PubMed ID: 26691470
    [Abstract] [Full Text] [Related]

  • 16. [Characterization and determination of antibiotic resistance profiles of a single clone Acinetobacter baumannii strains isolated from blood cultures].
    Karagöz A, Baran I, Aksu N, Acar S, Durmaz R.
    Mikrobiyol Bul; 2014 Oct 01; 48(4):566-76. PubMed ID: 25492652
    [Abstract] [Full Text] [Related]

  • 17. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
    Wang YC, Kuo SC, Yang YS, Lee YT, Chiu CH, Chuang MF, Lin JC, Chang FY, Chen TL.
    Antimicrob Agents Chemother; 2016 Aug 01; 60(8):4670-6. PubMed ID: 27216052
    [Abstract] [Full Text] [Related]

  • 18. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).
    Henwood CJ, Gatward T, Warner M, James D, Stockdale MW, Spence RP, Towner KJ, Livermore DM, Woodford N.
    J Antimicrob Chemother; 2002 Mar 01; 49(3):479-87. PubMed ID: 11864948
    [Abstract] [Full Text] [Related]

  • 19. In Vitro Activities of Tigecycline in Combination with Amikacin or Colistin Against Carbapenem-Resistant Acinetobacter baumannii.
    Wu H, Feng H, He L, Zhang H, Xu P.
    Appl Biochem Biotechnol; 2021 Dec 01; 193(12):3867-3876. PubMed ID: 34524633
    [Abstract] [Full Text] [Related]

  • 20. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
    Deveci A, Coban AY, Acicbe O, Tanyel E, Yaman G, Durupinar B.
    J Chemother; 2012 Oct 01; 24(5):247-52. PubMed ID: 23182043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.